2026Q1
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| PAVmed Inc. | 10% Owner | 31,302,444 | Feb 20, 2024 |
| Aklog Lishan | — | 1,466,627 | Feb 21, 2025 |
| McGrath Dennis M | — | 1,343,569 | Feb 21, 2025 |
| O'Neil Shaun | — | 826,763 | Feb 21, 2025 |
| Wurtman David F | — | 705,500 | Oct 13, 2021 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 20, 2026 | Feb 24, 2026 | Aklog Lishan | CEO | Neutral | 90.0 | +2,170,000 | 147.96% | ✗ | - |
| Feb 20, 2026 | Feb 24, 2026 | Matheis Dennis | Director | Neutral | 90.0 | +123,000 | 18.48% | ✗ | - |
| Feb 20, 2026 | Feb 24, 2026 | White Debra | Director | Neutral | 90.0 | +123,000 | 109.04% | ✗ | - |
| Feb 20, 2026 | Feb 24, 2026 | Sparks Ronald M | Director | Neutral | 90.0 | +123,000 | 62.29% | ✗ | - |
| Feb 20, 2026 | Feb 24, 2026 | SOKOLOV JACQUE J | Director | Neutral | 90.0 | +123,000 | 62.29% | ✗ | - |
| Feb 20, 2026 | Feb 24, 2026 | PALUMBO JOHN R | Director | Neutral | 90.0 | +123,000 | 57.21% | ✗ | - |
| Feb 20, 2026 | Feb 24, 2026 | Lapidus Stanley | Director | Neutral | 90.0 | +123,000 | 57.37% | ✗ | - |
| Feb 20, 2026 | Feb 24, 2026 | Cox James L | Director | Neutral | 90.0 | +123,000 | 43.60% | ✗ | - |
| Feb 20, 2026 | Feb 24, 2026 | MCGRATH DENNIS M | CFO | Neutral | 90.0 | +470,000 | 34.98% | ✗ | - |
| Feb 20, 2026 | Feb 24, 2026 | O'Neil Shaun | COO | Neutral | 90.0 | +620,000 | 74.99% | ✗ | - |
| Feb 20, 2026 | Feb 24, 2026 | Gordon Michael Adam | General Counsel and Secretary | Neutral | 90.0 | +300,000 | 42.86% | ✗ | - |
| Oct 6, 2025 | Oct 7, 2025 | PALUMBO JOHN R | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 7, 2025 | PALUMBO JOHN R | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Aug 20, 2025 | Aug 22, 2025 | Matheis Dennis | Director | Buy | 95.0 | +100,000 | 17.69% | ✗ | $101.8K |
| May 20, 2025 | May 23, 2025 | Matheis Dennis | Director | Buy | 97.5 | +350,000 | 162.46% | ✗ | $457.6K |
| May 20, 2025 | May 22, 2025 | Matheis Dennis | Director | Buy | 97.5 | +350,000 | 100.00% | ✗ | $457.6K |
| Feb 20, 2025 | Feb 21, 2025 | O'Neil Shaun | COO | Neutral | 90.0 | +300,000 | 56.95% | ✗ | - |
| Feb 20, 2025 | Feb 21, 2025 | Aklog Lishan | CEO | Neutral | 90.0 | +300,000 | 25.72% | ✗ | - |
| Feb 20, 2025 | Feb 21, 2025 | SOKOLOV JACQUE J | Director | Neutral | 90.0 | +112,800 | 133.24% | ✗ | - |
| Feb 20, 2025 | Feb 21, 2025 | Lapidus Stanley | Director | Neutral | 90.0 | +112,800 | 111.03% | ✗ | - |
| Feb 20, 2025 | Feb 21, 2025 | Matheis Dennis | Director | Neutral | 90.0 | +112,800 | 225.94% | ✗ | - |
| Feb 20, 2025 | Feb 21, 2025 | Cox James L | Director | Neutral | 90.0 | +112,800 | 66.62% | ✗ | - |
| Feb 20, 2025 | Feb 21, 2025 | MCGRATH DENNIS M | CFO | Neutral | 90.0 | +300,000 | 28.75% | ✗ | - |
| Feb 20, 2025 | Feb 21, 2025 | Gordon Michael Adam | General Counsel and Secretary | Neutral | 90.0 | +300,000 | 75.00% | ✗ | - |
| Feb 20, 2025 | Feb 21, 2025 | White Debra | Director | Neutral | 90.0 | +112,800 | 100.00% | ✗ | - |
| Feb 20, 2025 | Feb 21, 2025 | Sparks Ronald M | Director | Neutral | 90.0 | +112,800 | 133.24% | ✗ | - |
| May 8, 2024 | May 9, 2024 | Matheis Dennis | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 9, 2024 | Matheis Dennis | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| May 7, 2024 | May 8, 2024 | Gordon Michael Adam | General Counsel and Secretary | Neutral | 90.0 | +400,000 | 100.00% | ✗ | - |
| May 7, 2024 | May 8, 2024 | O'Neil Shaun | COO | Neutral | 90.0 | +400,000 | 315.55% | ✗ | - |
| May 7, 2024 | May 8, 2024 | MCGRATH DENNIS M | CFO | Neutral | 90.0 | +400,000 | 62.15% | ✗ | - |
| May 7, 2024 | May 8, 2024 | Aklog Lishan | CEO | Neutral | 90.0 | +400,000 | 52.18% | ✗ | - |
| Feb 22, 2024 | Feb 23, 2024 | White Debra | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 22, 2024 | Feb 23, 2024 | Sparks Ronald M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 22, 2024 | Feb 23, 2024 | Lapidus Stanley | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 22, 2024 | Feb 23, 2024 | Cox James L | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 22, 2024 | Feb 23, 2024 | SOKOLOV JACQUE J | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 15, 2024 | Feb 20, 2024 | PAVmed Inc. | 10% Owner | Neutral | 27.5 | -3,331,747 | -9.62% | ✗ | - |
| Jan 26, 2024 | Jan 30, 2024 | PAVmed Inc. | 10% Owner | Buy | 100.0 | +3,331,771 | 10.64% | ✗ | $4.7M |
| Sep 25, 2023 | Sep 27, 2023 | Lapidus Stanley | Director | Sell | 18.8 | -29,947 | -22.77% | ✓ | $43.5K |
| Sep 20, 2023 | Sep 27, 2023 | Lapidus Stanley | Director | Sell | 46.3 | -3,917 | -2.89% | ✓ | $5.7K |
| Sep 20, 2023 | Sep 22, 2023 | Lapidus Stanley | Director | Sell | 47.5 | -3,917 | -2.89% | ✗ | $5.7K |
| Nov 30, 2022 | Apr 13, 2023 | PAVmed Inc. | 10% Owner | Buy | 96.3 | +3,375,230 | 5.92% | ✗ | $6.5M |
| Apr 6, 2023 | O'Neil Shaun | COO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 31, 2023 | Feb 2, 2023 | Sparks Ronald M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 31, 2023 | Feb 2, 2023 | White Debra | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 31, 2023 | Feb 2, 2023 | SOKOLOV JACQUE J | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 31, 2023 | Feb 2, 2023 | Lapidus Stanley | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 31, 2023 | Feb 2, 2023 | Cox James L | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 30, 2022 | Dec 2, 2022 | PAVmed Inc. | 10% Owner | Buy | 93.8 | +3,375,230 | 4.25% | ✗ | $6.5M |
| Sep 20, 2022 | Sep 22, 2022 | Lapidus Stanley | Director | Sell | 42.5 | -33,864 | -20.00% | ✗ | $57.7K |
| Aug 2, 2022 | Aug 2, 2022 | White Debra | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 2, 2022 | White Debra | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jun 7, 2022 | Jun 9, 2022 | Gordon Michael Adam | General Counsel | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 8, 2022 | Gordon Michael Adam | General Counsel | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 18, 2022 | Feb 24, 2022 | SOKOLOV JACQUE J | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 18, 2022 | Feb 23, 2022 | Angagaw Aster | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 18, 2022 | Feb 23, 2022 | Lapidus Stanley | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 18, 2022 | Feb 23, 2022 | Cox James L | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 18, 2022 | Feb 23, 2022 | Sparks Ronald M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 18, 2022 | Feb 23, 2022 | MCGRATH DENNIS M | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 18, 2022 | Feb 23, 2022 | Aklog Lishan | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 7, 2022 | Jan 10, 2022 | MCGRATH DENNIS M | CFO | Neutral | 90.0 | +60,000 | 10.63% | ✗ | - |
| Jan 7, 2022 | Jan 10, 2022 | Aklog Lishan | CEO | Neutral | 90.0 | +60,000 | 10.63% | ✗ | - |
| Oct 18, 2021 | Oct 20, 2021 | Sparks Ronald M | Director | Neutral | 90.0 | +84,660 | 100.00% | ✗ | - |
| Oct 18, 2021 | Oct 20, 2021 | PAVmed Inc. | 10% Owner | Buy | 88.8 | +571,428 | 2.09% | ✗ | $8M |
| Oct 13, 2021 | Cox James L | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 13, 2021 | Sparks Ronald M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 13, 2021 | Angagaw Aster | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 13, 2021 | Lapidus Stanley | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 13, 2021 | Wurtman David F | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 13, 2021 | SOKOLOV JACQUE J | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 13, 2021 | MCGRATH DENNIS M | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 13, 2021 | Aklog Lishan | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 13, 2021 | PAVmed Inc. | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - |